Haleon PLC (LSE:HLN) has announced the pricing details for a significant bond offering, expected to raise nearly £1 billion through its subsidiary. The FTSE 100-listed health company revealed that €750 million worth of Euro medium-term notes will be issued, maturing in 2028, with a fixed interest rate of 2.875%. In addition, another £300 million worth of notes, set to mature in 2033, will carry a fixed rate of 4.625%.
Proceeds from the bond offering will primarily be used to repay an existing bond set to mature next March, valued at £1.34 billion. The remaining funds will be allocated for general corporate purposes. This move is part of the company's ongoing financial strategy to manage debt and ensure its operations are supported with long-term financing.
Haleon UK Capital, a subsidiary of Haleon PLC, is managing the bond issuance, which is expected to close on September 18. Once completed, the notes will be listed on the International Securities Market (ISM) in London, allowing the company to tap into global debt markets for funding.
This bond offering follows a strategy aimed at refinancing existing obligations while securing additional funds for broader corporate activities. By issuing medium-term notes at fixed rates, Haleon is locking in predictable financing costs over the next several years, providing stability in the company’s financial planning. The different maturity periods for the notes, set for 2028 and 2033, offer a balanced approach to debt management, allowing the company to spread out its liabilities over time.
Despite this announcement, Haleon shares experienced a slight dip of 0.3% on Thursday. The market's muted reaction could reflect broader trends or investor caution around the bond issuance. However, this offering is a key part of the company's efforts to maintain financial flexibility and ensure it can meet upcoming obligations.
Haleon’s decision to issue bonds with varied maturity dates helps it strategically balance near-term and long-term debt management. The use of proceeds to refinance existing debt and support corporate objectives aligns with its broader financial strategy. By tapping into both Euro and pound-denominated markets, Haleon continues to diversify its funding sources, contributing to its financial resilience and operational efficiency.